FECAL CALPROTECTIN AS A MARKER OF INFLAMMATION IN THE COLON AT DIFFERENT VARIANTS OF CLOSTRIDIUM DIFFICILE-INFECTIONS COURSE IN CHILDREN
https://doi.org/10.22627/2072-8107-2013-12-2-12-16
Abstract
The article discusses possible application of determination of the fecal calprotectin level in children with antibiotic-associated diarrhea caused by Clostridium difficile — infection to detect inflammation in various parts of the gastrointestinal tract. It is shown that calprotectin is an informative non-invasive method that can estimate the degree of inflammatory changes of the intestinal mucosa in patients with different clinical variants of Clostridium difficile — infection. The highest levels of fecal calprotectin are characteristic of hemorrhagic colitis caused by this microorganism.
About the Authors
L. N. Mazankova
Russian Medical Academy of Postgraduate, Moscow
Russian Federation
Russian Federation
S. G. Gorbunov
Russian Medical Academy of Postgraduate, Moscow
Russian Federation
Russian Federation
B. Yunes
Russian Medical Academy of Postgraduate, Moscow
Russian Federation
Russian Federation
References
1. Захарова И.Н. Антибиотик-ассоциированные диареи у детей: проблема и решение / И.Н. Захарова, Л.Н. Мазанкова // Учебное пособие для врачей. — М., 2011. — 46 с. [Zakharova I.N., Mazankova L.N. Antibiotic-associated diarrhea in children: the problem and the solution of (training manual for doctors). — М., 2011. — 46 p. (In Russ.)]
2. Incidence and risk factors of oral antibiotic-associated diarrhea in outpatient pediatric population / D. Turke et al. // J. Pediatr. Gastroenterol. Nutr. — 2003. — № 37. — Р. 22—26.
3. Damrongmanee A., Ukarapol N. Incidence of antibiotic-associated diarrhea in a pediatric ambulatory care setting // J. Med. Assoc. Thai. — 2007. — № 90. — Р. 513—517.
4. Эпидемиология и клинические варианты Clostridium difficile-инфекции у детей / Л.Н. Мазанкова, Б. Юнес, С.Г. Горбунов, И.С. Курохтина // Детские инфекции. — 2012. — № 3. — С. 39—42. [Epidemiology and clinical variants of Clostridium difficile — infection in children / L.N. Mazankova, B. Younes, S.G. Gorbunov, I S. Kurokhtina // Children’s Infections. — 2012. — № 3. — P. 39—42. (In Russ.)]
5. Малов В.А. Антибиотикоассоцированные диареи // Клинич. микробиол. и антимикроб. химиотер. — 2002. — № 1. — С. 24—27. [Malov V.A. Antibiotic-associated diarrhea // Clinical Microbiol. Antimicrob. Chemotherapy. — 2002. — № 1. — P. 24— 27. (In Russ.)]
6. Josefsson S., Bunn S.K., Domellöf M. Fаecal calprotectin in very low birth weight infants // J. Pediatr. Gastroenterol. Nutr. — 2007. — № 4. — Р. 407—413.
7. Olafsdottir E., Aksnes L., Fluge G., Berstad A. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children // Acta Paediatr. — 2002. — № 1. — Р. 45— 50.
8. Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease / U.L. Fagerberg et al. // J. Pediatr. Gastroenterol. Nutr. — 2007. — № 4. — Р. 414—420. 9. Expression of calprotectin in colon mucosa and fecal of patients with ulcerative colitis / Liu W.B., Lü Y.M., Jin Z., Yang X.L. // Beijing Da Xue Xue Bao. — 2005. — № 2. — Р. 179—182.
9. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease / Costa F. еt al. // Am. J. Gastroenterol. — 2008. — № 8. — P. 2007—2014.
10. Faecal calprotectin in children with chronic gastrointestinal symptoms / Bremner A., Roked S., Robinson R., Phillips I. et al. // Acta Paediatr. — 2005. — № 12. — P. 1855—1858.
11. Faecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease / Bunn S.K., Bisset W.M., Main M.J., Golden B.E. // J. Pediatr. Gastroenterol. Nutr. — 2001. — № 1. — P. 14—22.
12. Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis / Carroll D., Corfield A., Spicer R., Cairns P. // Lancet. — 2003. — № 9354. — P. 310—311.
13. Faecal calprotectin: a marker of inflammation throughout the intestinal tract / Summerton C.B., Longlands M.G., Wiener K., Shreeve D.R. // Eur. J. Gastroenterol. Hepatol. — 2002. — № 8. — P. 841— 845.
14. Fecal calprotectin and elastase 1 determinations in patients with pancreatic diseases: a possible link between pancreatic insufficiency and intestinal inflammation / Pezzilli R. et al. // J. Gastroenterol. — 2007. — № 9. — P. 754—760.
15. Евстигнеев И.В. Иммунологические методы исследования в диагностике заболеваний толстого кишечника // Клиническая иммунология, аллергология, инфектология. — 2012. — № 1—2. — С. 22—32. [Yevstigneyev I.V. Immunological research methods in the diagnosis of diseases of the large intestine // Clinical immunology, Allergology, Infectology. — 2012. — № 1—2. — P. 22—32. (In Russ.)]
16. Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice / Berni Canani R. et al. // Dig. Liver Dis. — 2004. — № 36. — Р. 263—271.
Review
For citations:
Mazankova L.N., Gorbunov S.G., Yunes B. FECAL CALPROTECTIN AS A MARKER OF INFLAMMATION IN THE COLON AT DIFFERENT VARIANTS OF CLOSTRIDIUM DIFFICILE-INFECTIONS COURSE IN CHILDREN. CHILDREN INFECTIONS. 2013;12(2):12-16. (In Russ.) https://doi.org/10.22627/2072-8107-2013-12-2-12-16
Views:
1214
Email this article 